Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Christophe Sapin"'
Autor:
Philip J Mease, Daniel E Furst, Jeffrey R Lisse, Christophe Sapin, Kirstin Griffing, Sarah Ross, Paulo Reis, Aisha Vadhariya, Soumya Reddy
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Introduction An important consideration in the treatment of patients with psoriatic arthritis (PsA) is whether the addition of methotrexate (MTX) to biologics has greater efficacy than biologic monotherapy with respect to efficacy outcomes in these p
Externí odkaz:
https://doaj.org/article/6faa857d6ef441bdb3a0886d6b37c265
Autor:
Kristian Reich, Lars Erik Kristensen, Saxon D. Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 2 (2022)
Introduction: The randomised, open-label, assessor-blinded, parallel-group SPIRIT-H2H trial (NCT03151551) demonstrated superiority of ixekizumab over adalimumab in simultaneously achieving improvement in joint symptoms (American College of Rheumatolo
Externí odkaz:
https://doaj.org/article/77642b2d53ea4d6391423392ca2958f9
Autor:
Maxine X. Patel, Nawal Bent-Ennakhil, Christophe Sapin, Sylvie di Nicola, Jean-Yves Loze, Anna-Greta Nylander, Stephan Heres
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments. This apparent under-prescription of LAI anti
Externí odkaz:
https://doaj.org/article/b9eabd8fe0344e728550d897f03ebf99
Autor:
Susanne Hartz, Christophe Sapin, Bernd Schweikert, Chiara Malmberg, Mercedes Núñez, Tatiana Dilla
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/6ebbbc3e135f47f6a7147a057648c82d
Autor:
Adeline Ruyssen-Witrand, Richard Perry, Clare Watkins, George Braileanu, Gayathri Kumar, Sandeep Kiri, Debby Nott, Soyi Liu-Leage, Susanne Hartz, Christophe Sapin
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Background Biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs are used in patients with psoriatic arthritis (PsA), but few studies directly compare their clinical efficacy. In such situations, network meta-analysis
Externí odkaz:
https://doaj.org/article/79755242a35346c881866cdcd7174c8f
Publikováno v:
Drugs in Context, Pp 1-8 (2016)
Schizophrenia presents a substantial clinical and economic burden to the health-care system. In QUAlity of LIfe with AbiliFY Maintena (QUALIFY), a randomized head-to-head study of aripiprazole once-monthly 400 mg (AOM 400) compared with paliperidone
Externí odkaz:
https://doaj.org/article/3e604f008d544801a3b160b6bf45b225
Autor:
Steven G Potkin, Jean-Yves Loze, Carlos Forray, Ross A Baker, Christophe Sapin, Timothy Peters-Strickland, Maud Beillat, Anna-Greta Nylander, Peter Hertel, Simon Nitschky Schmidt, Anders Ettrup, Anna Eramo, Karina Hansen, Dieter Naber
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183475 (2017)
Schizophrenia is a chronic disease with negative impact on patients' employment status and quality of life. This post-hoc analysis uses data from the QUALIFY study to elucidate the relationship between work readiness and health-related quality of lif
Externí odkaz:
https://doaj.org/article/b5d30494aa3d4448b36c28ade08cdac6
Autor:
Dennis McGonagle, Arthur Kavanaugh, Iain McInnes, Lars-Erik Kristensen, Joseph F Merola, Bruce E Strober, Jeffrey R Lisse, Jennifer Pustizzi, Christophe Sapin, Rebecca Bolce, Christopher Ritchlin
Publikováno v:
Rheumatology. 62
Background/Aims Psoriatic nail disease is intimately linked to adjacent distal interphalangeal joint (DIP) disease, and it is important to ascertain whether DIP-nail complex behaves differently under different biological therapies. The aim of this an
Autor:
Millie Long, Javier Gisbert, Kim McGinnis, Marc Ferrante, Gerhard Rogler, Christophe Sapin, Theresa Hunter, Joe Milata, Seyedehsan Navabi
Publikováno v:
Gastroenterology. 164:S13-S14
INTRODUCTION Mirikizumab, an anti-IL23p19 antibody, has demonstrated safety and efficacy versus placebo across clinical remission, symptomatic remission, and endoscopic and histologic endpoints in patients with moderately-to-severely active ulcerativ
Autor:
Bruce Sands, Jianmin Wu, Christophe Sapin, Theresa Hunter Gibble, Cem Kayhan, Stefan Schreiber
Publikováno v:
American Journal of Gastroenterology. 117:S4-S5